Australia In Vitro Diagnostics Quality Control Market Size & Outlook
Related Markets
Australia in vitro diagnostics quality control market highlights
- The Australia in vitro diagnostics quality control market generated a revenue of USD 20.0 million in 2023 and is expected to reach USD 26.3 million by 2030.
- The Australia market is expected to grow at a CAGR of 4% from 2024 to 2030.
- In terms of segment, controls was the largest revenue generating product in 2023.
- Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.
In vitro diagnostics quality control market data book summary
| Market revenue in 2023 | USD 20.0 million |
| Market revenue in 2030 | USD 26.3 million |
| Growth rate | 4% (CAGR from 2023 to 2030) |
| Largest segment | Controls |
| Fastest growing segment | Calibrators |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Controls, Calibrators |
| Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
Other key industry trends
- In terms of revenue, Australia accounted for 1.6% of the global in vitro diagnostics quality control market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China in vitro diagnostics quality control market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 38.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vitro Diagnostics Quality Control Market Scope
In Vitro Diagnostics Quality Control Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Biorex Food Diagnostics | View profile | 101-250 | Antrim, Antrim, United Kingdom, Europe | https://biorexfooddiagnostics.com |
| Cone Bioproducts | View profile | 11-50 | Seguin, Texas, United States, North America | https://www.conebio.com |
| TRINA BIOREACTIVES | View profile | 11-50 | Nänikon, Zurich, Switzerland, Europe | http://www.trinabio.com |
| Microbiologics | View profile | 1-10 | Saint Cloud, Minnesota, United States, North America | http://www.microbiologics.com/ |
| Fortress Diagnostics | View profile | 51-100 | Antrim, Antrim, United Kingdom, Europe | https://www.fortressdiagnostics.com |
| Seracare Life Sciences | View profile | 51-100 | Milford, Massachusetts, United States, North America | http://www.seracare.com |
| Helena Laboratories | View profile | 501-1000 | Beaumont, Texas, United States, North America | https://www.helena.com/ |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Australia in vitro diagnostics quality control market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.5% in 2023. Horizon Databook has segmented the Australia in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of diseases like diabetes and cardiovascular disorders is growing in Australia. For instance, according to the Baker Heart and Diabetes Institute, over 500,000 individuals in Australia are suffering from atrial fibrillation, and its prevalence can largely be attributed to diabetes. In addition, the prevalence of cancer is growing in the country.
According to Cancer Australia, more than 162,000 cancer cases were estimated to be diagnosed in 2022, and this number is expected to rise to 239,770 by 2030. Furthermore, in 2022, over 1.3 million people in the country had diabetes.
In addition, one in four people living with diabetes remains undiagnosed. The high burden of diseases in the country is expected to create growth opportunities for IVD tests and quality control. In Australia, clinical laboratory tests have major economic value.
Reasons to subscribe to Australia in vitro diagnostics quality control market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia in vitro diagnostics quality control market databook
-
Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Australia in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)
Australia In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
